Search research articles
Contact Us
Filters
Showing results (51-60 of 114) with videos related to
Page
of 12
Sort By:
Biomedicine / [Publiee Pour L'A.A.I.C.I.G.]
|
December 10, 1974
[Variation in the pharmacologic affects of decarboxylase inhibitor in variable doses in man]
P Castaigne, P Rondot, A Taberlet, et al.
European Neurology
|
January 1, 1987
Clinical trial of Madopar HBS in parkinsonian patients with fluctuating drug response after long-term levodopa therapy
P Rondot, M Ziegler, N Aymard, et al.
Therapie
|
September 1, 1975
[Development of studies on the treatment of Parkinson syndromes using levodopa. I. Short- and medium-term (2 years) effects of the combination levodopa decarboxylase inhibitor]
P Rondot, J L Ribadeau Dumas, P Cardon
Therapie
|
March 1, 1977
[Development of studies on the treatment of parkinsonian syndromes with levodopa. II. Long-term effects of L-DOPA alone or in combination with a decarboxylase inhibitor]
J L Rabadeau Dumas, P Rondot, P Cardon
Brain : a Journal of Neurology
|
June 1, 1977
Visuomotor ataxia
P Rondot, J de Recondo, J L Dumas
Revue Neurologique
|
January 1, 1992
[Dopa-sensitive dystonia]
P Rondot, J Aicardi, F Goutières, et al.
Revue Neurologique
|
January 1, 1987
[Controlled release levodopa-benserazide and changes in efficacy during treatment of Parkinson's disease]
P Rondot, M Ziegler, N Aymard, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
October 1, 1987
A comparative evaluation of the short orientation memory concentration test of cognitive impairment
P Davous, Y Lamour, E Debrand, et al.
Bulletin De L'Academie Nationale De Medecine
|
July 28, 2001
[Topography of secondary dystonia lesions]
P Rondot, N Bathien, P Tempier, et al.
Neurology
|
November 1, 1989
Effect of controlled-release carbidopa/levodopa on motor performance in advanced Parkinson's disease
P Rondot, M Ziegler, N Aymard, et al.
Page
of 12
Search research articles
Search
Showing results (51-60 of 114) with videos related to
Sort By:
Page
of 12
Biomedicine / [Publiee Pour L'A.A.I.C.I.G.]
|
December 10, 1974
[Variation in the pharmacologic affects of decarboxylase inhibitor in variable doses in man]
P Castaigne, P Rondot, A Taberlet, et al.
European Neurology
|
January 1, 1987
Clinical trial of Madopar HBS in parkinsonian patients with fluctuating drug response after long-term levodopa therapy
P Rondot, M Ziegler, N Aymard, et al.
Therapie
|
September 1, 1975
[Development of studies on the treatment of Parkinson syndromes using levodopa. I. Short- and medium-term (2 years) effects of the combination levodopa decarboxylase inhibitor]
P Rondot, J L Ribadeau Dumas, P Cardon
Therapie
|
March 1, 1977
[Development of studies on the treatment of parkinsonian syndromes with levodopa. II. Long-term effects of L-DOPA alone or in combination with a decarboxylase inhibitor]
J L Rabadeau Dumas, P Rondot, P Cardon
Brain : a Journal of Neurology
|
June 1, 1977
Visuomotor ataxia
P Rondot, J de Recondo, J L Dumas
Revue Neurologique
|
January 1, 1992
[Dopa-sensitive dystonia]
P Rondot, J Aicardi, F Goutières, et al.
Revue Neurologique
|
January 1, 1987
[Controlled release levodopa-benserazide and changes in efficacy during treatment of Parkinson's disease]
P Rondot, M Ziegler, N Aymard, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
October 1, 1987
A comparative evaluation of the short orientation memory concentration test of cognitive impairment
P Davous, Y Lamour, E Debrand, et al.
Bulletin De L'Academie Nationale De Medecine
|
July 28, 2001
[Topography of secondary dystonia lesions]
P Rondot, N Bathien, P Tempier, et al.
Neurology
|
November 1, 1989
Effect of controlled-release carbidopa/levodopa on motor performance in advanced Parkinson's disease
P Rondot, M Ziegler, N Aymard, et al.
Page
of 12